Sens. Thom Tillis and Chris Coons have outlined four principles for new patent eligibility legislation in a message to technology and pharmaceutical company representatives and others in advance of a fourth closed-door meeting on their effort.
Aides to Tillis (R-N.C.), the chairman of the Senate Judiciary Committee’s IP subcommittee and Coons (D-Del.), its ranking member, will present a “skeletal outline of legislation” at an April 17 meeting with industry and trade group representatives, according to a March 26 email from the aides obtained by Bloomberg Law. A spokesman for Tillis confirmed the email.
The two lawmakers have convened three private ...